Buy Moleculin Biotech Stock | MBRX Stock Price & Latest News | Public.com
MBRX

Moleculin Biotech

$0.00 (0.00%)Today
    Small Market Cap
    View Moleculin Biotech (MBRX) stock trends here

    About MBRX

    Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which focuses on the development of oncology drug candidates. Its Annamycin product candidate helps in the treatment of relapsed or refractory acute myeloid leukemia. The company's preclinical small mol...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.34
    -0.68
    -1.02
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.50

    Actual EPS
    Q1 2021

    Stats

    Market Cap$123,62M
    Volume638,2k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$11.82
    1 Year Low$1.94
    Open$4.35
    High$4.38
    Low$4.02

    Buy any stock with any amount of money.

    Download the App
    Download the app